                         SEQUENCE LISTING

<110>  Massachusetts Institute of Technology
 
<120>  SYSTEMS AND METHODS FOR USING BEHAVIOR DATA OF IMPURITIES AND TARGET PROTEINS TO DESIGN DOWNSTREAM PROCESSES

<130>  M0925.70562WO00

<140>  Not Yet Assigned
<141>  Concurrently Herewith

<150>  US 62/646,236
<151>  2018-03-21

<150>  US 62/644,285
<151>  2018-03-16

<150>  US 62/553,105
<151>  2017-08-31

<150>  US 62/553,765
<151>  2017-07-18

<150>  US 62/480,418
<151>  2017-04-01

<150>  US 62/480,422
<151>  2017-04-01

<150>  US 62/480,426
<151>  2017-04-01

<150>  US 62/480,427
<151>  2017-04-01

<150>  US 62/480,428
<151>  2017-04-01

<150>  US 62/480,430
<151>  2017-04-01

<150>  US 62/480,432
<151>  2017-04-01

<150>  US 62/480,435
<151>  2017-04-01

<150>  US 62/480,436
<151>  2017-04-01

<150>  US 62/480,438
<151>  2017-04-01


<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  128
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  1

Met Ala Asp Val Gln Leu Gln Ala Ser Gly Gly Gly Leu Ala Gln Ala 
1               5                   10                  15      


Gly Asp Ser Leu Thr Leu Ser Cys Ala Ala Ser Gly Arg Thr Phe Ser 
            20                  25                  30          


Gly Tyr Val Val Gly Trp Phe Arg Gln Ala Pro Gly Ala Glu Arg Glu 
        35                  40                  45              


Phe Val Gly Ala Ile Arg Trp Ser Glu Asp Ser Thr Trp Tyr Gly Asp 
    50                  55                  60                  


Ser Met Lys Gly Arg Ile Leu Ile Ser Arg Asn Asn Ile Lys Asn Thr 
65                  70                  75                  80  


Val Asn Leu Gln Met Phe Asn Leu Lys Pro Glu Asp Thr Ala Val Tyr 
                85                  90                  95      


Val Cys Ala Ala Gly Ala Gly Asp Ile Val Thr Thr Glu Thr Ser Tyr 
            100                 105                 110         


Asn Tyr Trp Gly Arg Gly Thr Gln Val Thr Val Ser Ser Arg Gly Arg 
        115                 120                 125             


<210>  2
<211>  126
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  2

Met Ala Asp Val Gln Leu Gln Ala Ser Gly Gly Gly Phe Val Gln Pro 
1               5                   10                  15      


Gly Asp Ser Leu Ser Leu Ser Cys Ala Ala Ser Gly Gly Thr Phe Ser 
            20                  25                  30          


Ser Tyr Ser Ile Gly Trp Phe Arg Gln Gly Pro Gly Lys Glu Arg Glu 
        35                  40                  45              


Phe Val Ala Thr Ile Ser Ser Ser Asp Ser Pro Trp Tyr Gly Glu Pro 
    50                  55                  60                  


Ala Lys Gly Arg Phe Thr Val Ala Arg Val Asn Ala Lys Asn Thr Ala 
65                  70                  75                  80  


Tyr Leu His Leu Asn Arg Leu Lys Pro Glu Asp Thr Ala Thr Tyr Tyr 
                85                  90                  95      


Cys Ala Ala Gly Ser Val Gln His Met Ala Asn Glu Asn Glu Tyr Val 
            100                 105                 110         


Tyr Trp Gly Gln Gly Thr Gln Val Thr Val Ser Ser Gly Arg 
        115                 120                 125     


